The global Autonomic Dysreflexia (AD) Treatment Market is a critical sector within neurorehabilitation and emergency medicine. As a life-threatening medical emergency primarily affecting individuals with spinal cord injuries (SCI), the demand for rapid-response pharmacological and non-pharmacological interventions has reached new heights in 2026. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/